Poplar Forest Capital’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-4,658
| Closed | -$253K | – | 52 |
|
|
2022
Q2 | $253K | Sell |
4,658
-2,267
| -33% | -$125K | 0.03% | 50 |
|
|
2022
Q1 | $377K | Sell |
6,925
-208
| -3% | -$11.3K | 0.04% | 49 |
|
|
2021
Q4 | $393K | Hold |
7,133
| – | – | 0.04% | 48 |
|
|
2021
Q3 | $341K | Hold |
7,133
| – | – | 0.04% | 63 |
|
|
2021
Q2 | $355K | Hold |
7,133
| – | – | 0.03% | 66 |
|
|
2021
Q1 | $318K | Hold |
7,133
| – | – | 0.03% | 68 |
|
|
2020
Q4 | $328K | Hold |
7,133
| – | – | 0.04% | 57 |
|
|
2020
Q3 | $336K | Hold |
7,133
| – | – | 0.04% | 49 |
|
|
2020
Q2 | $364K | Buy |
7,133
+186
| +3% | +$9.54K | 0.04% | 49 |
|
|
2020
Q1 | $329K | Sell |
6,947
-142
| -2% | -$7.58K | 0.05% | 54 |
|
|
2019
Q4 | $416K | Buy |
7,089
+240
| +4% | +$13.3K | 0.04% | 49 |
|
|
2019
Q3 | $365K | Sell |
6,849
-40
| -0.6% | -$2.06K | 0.03% | 48 |
|
|
2019
Q2 | $345K | Hold |
6,889
| – | – | 0.03% | 52 |
|
|
2019
Q1 | $360K | Buy |
6,889
+108
| +2% | +$5.4K | 0.02% | 51 |
|
|
2018
Q4 | $324K | Hold |
6,781
| – | – | 0.02% | 53 |
|
|
2018
Q3 | $340K | Buy |
6,781
+136
| +2% | +$6.91K | 0.03% | 58 |
|
|
2018
Q2 | $335K | Hold |
6,645
| – | – | 0.03% | 62 |
|
|
2018
Q1 | $325K | Hold |
6,645
| – | – | 0.03% | 61 |
|
|
2017
Q4 | $295K | Hold |
6,645
| – | – | 0.02% | 58 |
|
|
2017
Q3 | $337K | Hold |
6,645
| – | – | 0.03% | 60 |
|
|
2017
Q2 | $358K | Hold |
6,645
| – | – | 0.03% | 61 |
|
|
2017
Q1 | $350K | Hold |
6,645
| – | – | 0.03% | 61 |
|
|
2016
Q4 | $320K | Hold |
6,645
| – | – | 0.03% | 49 |
|
|
2016
Q3 | $358K | Hold |
6,645
| – | – | 0.03% | 47 |
|
|
2016
Q2 | $360K | Hold |
6,645
| – | – | 0.03% | 49 |
|
|
2016
Q1 | $337K | Sell |
6,645
-4,280
| -39% | -$213K | 0.03% | 69 |
|
|
2015
Q4 | $551K | Hold |
10,925
| – | – | 0.05% | 66 |
|
|
2015
Q3 | $525K | Hold |
10,925
| – | – | 0.05% | 63 |
|
|
2015
Q2 | $569K | Hold |
10,925
| – | – | 0.04% | 62 |
|
|
2015
Q1 | $630K | Hold |
10,925
| – | – | 0.05% | 62 |
|
|
2014
Q4 | $584K | Hold |
10,925
| – | – | 0.05% | 61 |
|
|
2014
Q3 | $628K | Hold |
10,925
| – | – | 0.06% | 62 |
|
|
2014
Q2 | $730K | Hold |
10,925
| – | – | 0.07% | 43 |
|
|
2014
Q1 | $730K | Hold |
10,925
| – | – | 0.08% | 41 |
|
|
2013
Q4 | $729K | Hold |
10,925
| – | – | 0.09% | 39 |
|
|
2013
Q3 | $685K | Hold |
10,925
| – | – | 0.09% | 39 |
|
|
2013
Q2 | $682K | Buy |
+10,925
| New | +$693K | 0.1% | 40 |
|
Other funds holding GSK
Poplar Forest Capital's GSK Position: Q3 2022 in Review
Poplar Forest Capital sold out of GSK (GSK) in Q3 2022, closing a stake of 4,658 shares — an estimated $253K sold.
Poplar Forest Capital first reported a position in GSK in Q2 2013 and held it in 37 quarters. The position peaked at $730K in Q2 2014. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.
- Poplar Forest Capital reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
- Poplar Forest Capital sold 4,658 GSK shares in Q3 2022, an estimated $253K.
- Poplar Forest Capital first reported a position in GSK in Q2 2013 and held it in 37 quarters.
- Poplar Forest Capital's GSK position peaked at $730K in Q2 2014.
- 742 funds tracked by Wall St. Rank held GSK as of Q3 2022.
Based on Poplar Forest Capital's 13F filing for Q3 2022, filed 3 Nov 2022.